Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Ischemic vs nonischemic heart failure--does etiology matter?].

F Follath1

  • 1Departement Innere Medizin, Universitätsspital Zürich. dimscy@usz.unizh.ch

Therapeutische Umschau. Revue Therapeutique
|June 22, 2000
PubMed
Summary

Understanding the cause of heart failure is crucial. Ischemic heart failure generally has a worse prognosis, though some drug responses differ between ischemic and non-ischemic heart failure.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic impact of systemic inflammatory diseases in elderly patients with congestive heart failure.

QJM : monthly journal of the Association of Physicians·2013
Same author

The role of β-blockers in the management of hypertension: an Asian perspective.

Current medical research and opinion·2011
Same author

Clinical presentation, management and outcomes in the Acute Heart Failure Global Survey of Standard Treatment (ALARM-HF).

Intensive care medicine·2011
Same author

Ethical considerations in cardiovascular prevention.

Fundamental & clinical pharmacology·2009
Same author

Amiodarone inhibits arterial thrombus formation and tissue factor translation.

Arteriosclerosis, thrombosis, and vascular biology·2008
Same author

[Heart failure in men and women: important differences in the diagnostic workup and treatment].

Nederlands tijdschrift voor geneeskunde·2008

Area of Science:

  • Cardiology
  • Heart Failure Research
  • Clinical Trials

Context:

  • Prognosis of ischemic heart failure is often worse than non-ischemic heart failure in large trials.
  • Therapeutic responses to certain medications vary significantly between these etiologies.
  • Identifying the underlying cause of heart failure is essential for effective management.

Purpose:

  • To compare the prognosis and therapeutic responses in ischemic versus non-ischemic heart failure.
  • To highlight the importance of identifying specific etiologies like hibernating myocardium, hypertensive heart disease, and alcoholic cardiomyopathy.
  • To emphasize the need for etiological diagnosis in all heart failure patients.

Summary:

  • Large-scale trials indicate a poorer prognosis for ischemic heart failure compared to non-ischemic forms.
  • While core medications show similar efficacy, non-ischemic heart failure patients exhibit better responses to amiodarone, amlodipine, digoxin, and growth hormone.
  • Recognizing hibernating myocardium is vital for potential improvement via revascularization.
  • Specific interventions exist for hypertensive heart disease, alcoholic cardiomyopathy, and tachyarrhythmia-induced LV dysfunction.

Impact:

  • Highlights the prognostic differences and differential drug responses in heart failure etiologies.
  • Underscores the clinical significance of diagnosing specific causes for targeted treatment strategies.
  • Emphasizes the need for etiological investigation to optimize patient outcomes in heart failure management.

Related Experiment Videos